Prognostic Factors and Recurrence in Breast Cancer: Experience at the National Cancer Institute of Mexico

Table 3

The number of positive lymph nodes and the tumor responses in patients who were treated with neoadjuvant treatment.

Histopathology of axillary LNs	Recurrence group	Control group
Negative	16 (26.67%)	37 (61.67%)
Positive	44 (73.33%)	23 (38.33%)
Number of positive axillary LNs
0	17	36
1	6	7
2	8	2
3	7	5
4	3	2
5	2	2
6	5	4
7	2	0
8	2	0
9	3	1
10	1	0
>10	1	0
>15	1	1
>20	2	0
Pathological response %
Complete	8 (13.33%)	19 (31.67%)
90	15 (25.00%)	11 (18.33%)
80	2 (3.33%)	4 (6.67%)
70	3 (5.00%)	1 (1.67%)
60	2 (3.33%)	2 (3.33%)
50	5 (8.33%)	5 (8.33%)
30	0	2 (3.33%)
10	4 (6.67%)	3 (5.00%)
Unknown	21 (35.00%)	13 (21.67%)
Total	60	60